Archive for category: Life Sciences

EPISURF MEDICAL OBTAINS FURTHER GRANTED PATENT IN EUROPE

EPISURF MEDICAL OBTAINS FURTHER GRANTED PATENT IN EUROPE

/ June 13, 2017 8:58 am

The European patent office EPO has announced its intention to grant another European patent for Episurf Medical. The patent Implant specific drill bit comprises one of the tools in Episurf Medical’s kit with surgical instruments used for implantation of the […]

Titan Medical Granted European Patent Related to SPORT Surgical System Robotic Instruments

Titan Medical Granted European Patent Related to SPORT Surgical System Robotic Instruments

/ June 13, 2017 8:51 am

Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces the publication of European Patent No. EP2996613, titled “Articulated Tool Positioner […]

Rosetta Genomics Granted European Patent Allowance Covering RosettaGX Cancer Origin Assay

Rosetta Genomics Granted European Patent Allowance Covering RosettaGX Cancer Origin Assay

/ May 26, 2017 8:09 am

Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, announces that the European Patent Office has granted a patent allowance for European patent application No. 11842532.1, titled […]

Prescient Therapeutics granted European patent for its cancer therapy

Prescient Therapeutics granted European patent for its cancer therapy

/ May 17, 2017 8:04 am

Clinical-stage oncology company Prescient Therapeutics Ltd (ASX: PTX) is pleased to announce that a new patent has been granted in Europe providing platform technology protection for its lead clinical compound PTX-200 (triciribine phosphate). The patent “Effective treatment of tumors and […]

Rosetta Genomics Expands Patent Portfolio in Europe and Japan

Rosetta Genomics Expands Patent Portfolio in Europe and Japan

/ May 10, 2017 8:20 am

Granted European Patent Allowance and Japanese Patent for microRNA-based Lung Cancer Classifier Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, announces that the European Patent Office […]

CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE

CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE

/ May 5, 2017 8:12 am

 CEL-SCI Corporation (NYSE MKT: CVM) today announced that it has been notified that it will be granted a new patent on Multikine* (Leukocyte Interleukin, Injection), its investigational cancer immunotherapy, from the European Patent Office. The patent is titled: A METHOD FOR MODULATING HLA […]

ORAMED GRANTED EUROPEAN PATENT FOR COMBINATION ORAL INSULIN AND GLP-1 ANALOG CAPSULE

ORAMED GRANTED EUROPEAN PATENT FOR COMBINATION ORAL INSULIN AND GLP-1 ANALOG CAPSULE

/ May 5, 2017 8:02 am

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the European Patent Office has granted the Company a patent titled, “Methods and Compositions for Treating Diabetes: Capsules containing […]

Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent

Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent

/ April 26, 2017 9:30 am

– Patent covers foundational CRISPR/Cas9 inventions that Intellia sublicensed for use in human therapeutics – Patent covers compositions of CRISPR single guide RNA technology for use in non-cellular and cellular settings, including eukaryotic cells CAMBRIDGE, Mass., April 11, 2017 (GLOBEWIRE) […]

Bee Vectoring Technologies has Milestone Patent Granted in Europe

Bee Vectoring Technologies has Milestone Patent Granted in Europe

/ April 20, 2017 8:00 am

• First patent granted by the European Patent Office (EPO) • Patent can cover up to 38 European countries Mississauga, ON – April 13, 2017 – Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (TSXV: BEE) is pleased to […]

VistaGen Therapeutics Receives European Patent Office Notice of Intention to Grant European Patent for AV-101

VistaGen Therapeutics Receives European Patent Office Notice of Intention to Grant European Patent for AV-101

/ April 12, 2017 8:18 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, announced today that the European Patent Office (EPO) has issued a Notice of Intention to Grant the […]